HK, There was much less robust and compelling data with HCQ early on and the WH, press, social media, etc ran with it. Why not think that something as “benign” as VASCEPA with the positive data we have recently been provided couldn’t gain some serious traction? Who wouldn’t take it?
Market Data 
Markets
AI
